Table of Contents Chapter 1 Overview of Hairy Cell Leukemia Therapeutics 1.1 Definition of Hairy Cell Leukemia Therapeutics in This Report 1.2 Commercial Types of Hairy Cell Leukemia Therapeutics 1.2.1 Dezapelisib 1.2.2 ELB-021 1.2.3 Ibrutinib 1.2.4 AGS-67E 1.2.5 ARABS-4 1.2.6 Others 1.3 Downstream Application of Hairy Cell Leukemia Therapeutics 1.3.1 Hospital 1.3.2 Clinic 1.3.3 Others 1.4 Development History of Hairy Cell Leukemia Therapeutics 1.5 Market Status and Trend of Hairy Cell Leukemia Therapeutics 2013-2023 1.5.1 Global Hairy Cell Leukemia Therapeutics Market Status and Trend 2013-2023 1.5.2 Regional Hairy Cell Leukemia Therapeutics Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Hairy Cell Leukemia Therapeutics 2013-2017 2.2 Sales Market of Hairy Cell Leukemia Therapeutics by Regions 2.2.1 Sales Volume of Hairy Cell Leukemia Therapeutics by Regions 2.2.2 Sales Value of Hairy Cell Leukemia Therapeutics by Regions 2.3 Production Market of Hairy Cell Leukemia Therapeutics by Regions 2.4 Global Market Forecast of Hairy Cell Leukemia Therapeutics 2018-2023 2.4.1 Global Market Forecast of Hairy Cell Leukemia Therapeutics 2018-2023 2.4.2 Market Forecast of Hairy Cell Leukemia Therapeutics by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Hairy Cell Leukemia Therapeutics by Types 3.2 Sales Value of Hairy Cell Leukemia Therapeutics by Types 3.3 Market Forecast of Hairy Cell Leukemia Therapeutics by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Hairy Cell Leukemia Therapeutics by Downstream Industry 4.2 Global Market Forecast of Hairy Cell Leukemia Therapeutics by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Hairy Cell Leukemia Therapeutics Market Status by Countries 5.1.1 North America Hairy Cell Leukemia Therapeutics Sales by Countries (2013-2017) 5.1.2 North America Hairy Cell Leukemia Therapeutics Revenue by Countries (2013-2017) 5.1.3 United States Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 5.1.4 Canada Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 5.1.5 Mexico Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 5.2 North America Hairy Cell Leukemia Therapeutics Market Status by Manufacturers 5.3 North America Hairy Cell Leukemia Therapeutics Market Status by Type (2013-2017) 5.3.1 North America Hairy Cell Leukemia Therapeutics Sales by Type (2013-2017) 5.3.2 North America Hairy Cell Leukemia Therapeutics Revenue by Type (2013-2017) 5.4 North America Hairy Cell Leukemia Therapeutics Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Hairy Cell Leukemia Therapeutics Market Status by Countries 6.1.1 Europe Hairy Cell Leukemia Therapeutics Sales by Countries (2013-2017) 6.1.2 Europe Hairy Cell Leukemia Therapeutics Revenue by Countries (2013-2017) 6.1.3 Germany Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 6.1.4 UK Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 6.1.5 France Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 6.1.6 Italy Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 6.1.7 Russia Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 6.1.8 Spain Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 6.1.9 Benelux Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 6.2 Europe Hairy Cell Leukemia Therapeutics Market Status by Manufacturers 6.3 Europe Hairy Cell Leukemia Therapeutics Market Status by Type (2013-2017) 6.3.1 Europe Hairy Cell Leukemia Therapeutics Sales by Type (2013-2017) 6.3.2 Europe Hairy Cell Leukemia Therapeutics Revenue by Type (2013-2017) 6.4 Europe Hairy Cell Leukemia Therapeutics Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Hairy Cell Leukemia Therapeutics Market Status by Countries 7.1.1 Asia Pacific Hairy Cell Leukemia Therapeutics Sales by Countries (2013-2017) 7.1.2 Asia Pacific Hairy Cell Leukemia Therapeutics Revenue by Countries (2013-2017) 7.1.3 China Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 7.1.4 Japan Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 7.1.5 India Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 7.1.6 Southeast Asia Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 7.1.7 Australia Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 7.2 Asia Pacific Hairy Cell Leukemia Therapeutics Market Status by Manufacturers 7.3 Asia Pacific Hairy Cell Leukemia Therapeutics Market Status by Type (2013-2017) 7.3.1 Asia Pacific Hairy Cell Leukemia Therapeutics Sales by Type (2013-2017) 7.3.2 Asia Pacific Hairy Cell Leukemia Therapeutics Revenue by Type (2013-2017) 7.4 Asia Pacific Hairy Cell Leukemia Therapeutics Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Hairy Cell Leukemia Therapeutics Market Status by Countries 8.1.1 Latin America Hairy Cell Leukemia Therapeutics Sales by Countries (2013-2017) 8.1.2 Latin America Hairy Cell Leukemia Therapeutics Revenue by Countries (2013-2017) 8.1.3 Brazil Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 8.1.4 Argentina Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 8.1.5 Colombia Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 8.2 Latin America Hairy Cell Leukemia Therapeutics Market Status by Manufacturers 8.3 Latin America Hairy Cell Leukemia Therapeutics Market Status by Type (2013-2017) 8.3.1 Latin America Hairy Cell Leukemia Therapeutics Sales by Type (2013-2017) 8.3.2 Latin America Hairy Cell Leukemia Therapeutics Revenue by Type (2013-2017) 8.4 Latin America Hairy Cell Leukemia Therapeutics Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Hairy Cell Leukemia Therapeutics Market Status by Countries 9.1.1 Middle East and Africa Hairy Cell Leukemia Therapeutics Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Hairy Cell Leukemia Therapeutics Revenue by Countries (2013-2017) 9.1.3 Middle East Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 9.1.4 Africa Hairy Cell Leukemia Therapeutics Market Status (2013-2017) 9.2 Middle East and Africa Hairy Cell Leukemia Therapeutics Market Status by Manufacturers 9.3 Middle East and Africa Hairy Cell Leukemia Therapeutics Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Hairy Cell Leukemia Therapeutics Sales by Type (2013-2017) 9.3.2 Middle East and Africa Hairy Cell Leukemia Therapeutics Revenue by Type (2013-2017) 9.4 Middle East and Africa Hairy Cell Leukemia Therapeutics Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Hairy Cell Leukemia Therapeutics 10.1 Global Economy Situation and Trend Overview 10.2 Hairy Cell Leukemia Therapeutics Downstream Industry Situation and Trend Overview Chapter 11 Hairy Cell Leukemia Therapeutics Market Competition Status by Major Manufacturers 11.1 Production Volume of Hairy Cell Leukemia Therapeutics by Major Manufacturers 11.2 Production Value of Hairy Cell Leukemia Therapeutics by Major Manufacturers 11.3 Basic Information of Hairy Cell Leukemia Therapeutics by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Hairy Cell Leukemia Therapeutics Major Manufacturer 11.3.2 Employees and Revenue Level of Hairy Cell Leukemia Therapeutics Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Hairy Cell Leukemia Therapeutics Major Manufacturers Introduction and Market Data 12.1 AbbVie Inc 12.1.1 Company profile 12.1.2 Representative Hairy Cell Leukemia Therapeutics Product 12.1.3 Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of AbbVie Inc 12.2 ARA Healthcare Pvt Ltd 12.2.1 Company profile 12.2.2 Representative Hairy Cell Leukemia Therapeutics Product 12.2.3 Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of ARA Healthcare Pvt Ltd 12.3 Astellas Pharma Inc. 12.3.1 Company profile 12.3.2 Representative Hairy Cell Leukemia Therapeutics Product 12.3.3 Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of Astellas Pharma Inc. 12.4 Cellectis SA 12.4.1 Company profile 12.4.2 Representative Hairy Cell Leukemia Therapeutics Product 12.4.3 Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of Cellectis SA 12.5 F. Hoffmann-La Roche Ltd 12.5.1 Company profile 12.5.2 Representative Hairy Cell Leukemia Therapeutics Product 12.5.3 Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd 12.6 Incyte Corp 12.6.1 Company profile 12.6.2 Representative Hairy Cell Leukemia Therapeutics Product 12.6.3 Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of Incyte Corp 12.7 Juno Therapeutics Inc 12.7.1 Company profile 12.7.2 Representative Hairy Cell Leukemia Therapeutics Product 12.7.3 Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of Juno Therapeutics Inc 12.8 MedImmune LLC 12.8.1 Company profile 12.8.2 Representative Hairy Cell Leukemia Therapeutics Product 12.8.3 Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of MedImmune LLC 12.9 Novartis AG 12.9.1 Company profile 12.9.2 Representative Hairy Cell Leukemia Therapeutics Product 12.9.3 Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of Novartis AG Chapter 13 Upstream and Downstream Market Analysis of Hairy Cell Leukemia Therapeutics 13.1 Industry Chain of Hairy Cell Leukemia Therapeutics 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Hairy Cell Leukemia Therapeutics 14.1 Cost Structure Analysis of Hairy Cell Leukemia Therapeutics 14.2 Raw Materials Cost Analysis of Hairy Cell Leukemia Therapeutics 14.3 Labor Cost Analysis of Hairy Cell Leukemia Therapeutics 14.4 Manufacturing Expenses Analysis of Hairy Cell Leukemia Therapeutics Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Dezapelisib Table Advantage and Disadvantage of ELB-021 Table Advantage and Disadvantage of Ibrutinib Table Advantage and Disadvantage of AGS-67E Table Advantage and Disadvantage of ARABS-4 Table Advantage and Disadvantage of Others Table Sales Volume of Hairy Cell Leukemia Therapeutics by Regions 2013-2017 Table Sales Value of Hairy Cell Leukemia Therapeutics by Regions 2013-2017 Table Production Volume of Hairy Cell Leukemia Therapeutics by Regions 2013-2017 Table Global Sales Volume of Hairy Cell Leukemia Therapeutics by Regions 2018-2023 Table Global Sales Value of Hairy Cell Leukemia Therapeutics by Regions 2018-2023 Table Global Production Volume of Hairy Cell Leukemia Therapeutics by Regions 2018-2023 Table Sales Volume of Hairy Cell Leukemia Therapeutics by Types 2013-2017 Table Sales Value of Hairy Cell Leukemia Therapeutics by Types 2013-2017 Table Sales Volume Forecast of Hairy Cell Leukemia Therapeutics by Types 2018-2023 Table Sales Value Forecast of Hairy Cell Leukemia Therapeutics by Types 2018-2023 Table Sales Volume of Hairy Cell Leukemia Therapeutics by Downstream Industry 2013-2017 Table Sales Volume Forecast of Hairy Cell Leukemia Therapeutics by Downstream Industry 2018-2023 Table North America Hairy Cell Leukemia Therapeutics Sales by Countries (2013-2017) Table North America Hairy Cell Leukemia Therapeutics Sales Share by Countries (2013-2017) Table North America Hairy Cell Leukemia Therapeutics Revenue by Countries (2013-2017) Table North America Hairy Cell Leukemia Therapeutics Revenue Market Share by Countries (2013-2017) Table North America Hairy Cell Leukemia Therapeutics Sales by Type (2013-2017) Table North America Hairy Cell Leukemia Therapeutics Sales Share by Type (2013-2017) Table North America Hairy Cell Leukemia Therapeutics Revenue by Type (2013-2017) Table North America Hairy Cell Leukemia Therapeutics Revenue Share by Type (2013-2017) Table North America Hairy Cell Leukemia Therapeutics Sales by Downstream Industry (2013-2017) Table North America Hairy Cell Leukemia Therapeutics Sales Share by Downstream Industry (2013-2017) Table Europe Hairy Cell Leukemia Therapeutics Sales by Countries (2013-2017) Table Europe Hairy Cell Leukemia Therapeutics Sales Share by Countries (2013-2017) Table Europe Hairy Cell Leukemia Therapeutics Revenue by Countries (2013-2017) Table Europe Hairy Cell Leukemia Therapeutics Revenue Market Share by Countries (2013-2017) Table Europe Hairy Cell Leukemia Therapeutics Sales by Type (2013-2017) Table Europe Hairy Cell Leukemia Therapeutics Sales Share by Type (2013-2017) Table Europe Hairy Cell Leukemia Therapeutics Revenue by Type (2013-2017) Table Europe Hairy Cell Leukemia Therapeutics Revenue Share by Type (2013-2017) Table Europe Hairy Cell Leukemia Therapeutics Sales by Downstream Industry (2013-2017) Table Europe Hairy Cell Leukemia Therapeutics Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Hairy Cell Leukemia Therapeutics Sales by Countries (2013-2017) Table Asia Pacific Hairy Cell Leukemia Therapeutics Sales Share by Countries (2013-2017) Table Asia Pacific Hairy Cell Leukemia Therapeutics Revenue by Countries (2013-2017) Table Asia Pacific Hairy Cell Leukemia Therapeutics Revenue Market Share by Countries (2013-2017) Table Asia Pacific Hairy Cell Leukemia Therapeutics Sales by Type (2013-2017) Table Asia Pacific Hairy Cell Leukemia Therapeutics Sales Share by Type (2013-2017) Table Asia Pacific Hairy Cell Leukemia Therapeutics Revenue by Type (2013-2017) Table Asia Pacific Hairy Cell Leukemia Therapeutics Revenue Share by Type (2013-2017) Table Asia Pacific Hairy Cell Leukemia Therapeutics Sales by Downstream Industry (2013-2017) Table Asia Pacific Hairy Cell Leukemia Therapeutics Sales Share by Downstream Industry (2013-2017) Table Latin America Hairy Cell Leukemia Therapeutics Sales by Countries (2013-2017) Table Latin America Hairy Cell Leukemia Therapeutics Sales Share by Countries (2013-2017) Table Latin America Hairy Cell Leukemia Therapeutics Revenue by Countries (2013-2017) Table Latin America Hairy Cell Leukemia Therapeutics Revenue Market Share by Countries (2013-2017) Table Latin America Hairy Cell Leukemia Therapeutics Sales by Type (2013-2017) Table Latin America Hairy Cell Leukemia Therapeutics Sales Share by Type (2013-2017) Table Latin America Hairy Cell Leukemia Therapeutics Revenue by Type (2013-2017) Table Latin America Hairy Cell Leukemia Therapeutics Revenue Share by Type (2013-2017) Table Latin America Hairy Cell Leukemia Therapeutics Sales by Downstream Industry (2013-2017) Table Latin America Hairy Cell Leukemia Therapeutics Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Hairy Cell Leukemia Therapeutics Sales by Regions (2013-2017) Table Middle East and Africa Hairy Cell Leukemia Therapeutics Sales Share by Regions (2013-2017) Table Middle East and Africa Hairy Cell Leukemia Therapeutics Revenue by Regions (2013-2017) Table Middle East and Africa Hairy Cell Leukemia Therapeutics Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Hairy Cell Leukemia Therapeutics Sales by Type (2013-2017) Table Middle East and Africa Hairy Cell Leukemia Therapeutics Sales Share by Type (2013-2017) Table Middle East and Africa Hairy Cell Leukemia Therapeutics Revenue by Type (2013-2017) Table Middle East and Africa Hairy Cell Leukemia Therapeutics Revenue Share by Type (2013-2017) Table Middle East and Africa Hairy Cell Leukemia Therapeutics Sales by Downstream Industry (2013-2017) Table Middle East and Africa Hairy Cell Leukemia Therapeutics Sales Share by Downstream Industry (2013-2017) Table Production Volume of Hairy Cell Leukemia Therapeutics by Major Manufacturers 2013-2017 Table Production Value of Hairy Cell Leukemia Therapeutics by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Hairy Cell Leukemia Therapeutics Major Manufacturer Table Employees and Revenue Level of Hairy Cell Leukemia Therapeutics Major Manufacturer Table Representative Hairy Cell Leukemia Therapeutics Product One of AbbVie Inc Table Representative Hairy Cell Leukemia Therapeutics Product Two of AbbVie Inc Table Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of AbbVie Inc 2013-2017 Table Representative Hairy Cell Leukemia Therapeutics Product One of ARA Healthcare Pvt Ltd Table Representative Hairy Cell Leukemia Therapeutics Product Two of ARA Healthcare Pvt Ltd Table Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of ARA Healthcare Pvt Ltd 2013-2017 Table Representative Hairy Cell Leukemia Therapeutics Product One of Astellas Pharma Inc. Table Representative Hairy Cell Leukemia Therapeutics Product Two of Astellas Pharma Inc. Table Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of Astellas Pharma Inc. 2013-2017 Table Representative Hairy Cell Leukemia Therapeutics Product One of Cellectis SA Table Representative Hairy Cell Leukemia Therapeutics Product Two of Cellectis SA Table Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of Cellectis SA 2013-2017 Table Representative Hairy Cell Leukemia Therapeutics Product One of F. Hoffmann-La Roche Ltd Table Representative Hairy Cell Leukemia Therapeutics Product Two of F. Hoffmann-La Roche Ltd Table Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd 2013-2017 Table Representative Hairy Cell Leukemia Therapeutics Product One of Incyte Corp Table Representative Hairy Cell Leukemia Therapeutics Product Two of Incyte Corp Table Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of Incyte Corp 2013-2017 Table Representative Hairy Cell Leukemia Therapeutics Product One of Juno Therapeutics Inc Table Representative Hairy Cell Leukemia Therapeutics Product Two of Juno Therapeutics Inc Table Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of Juno Therapeutics Inc 2013-2017 Table Representative Hairy Cell Leukemia Therapeutics Product One of MedImmune LLC Table Representative Hairy Cell Leukemia Therapeutics Product Two of MedImmune LLC Table Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of MedImmune LLC 2013-2017 Table Representative Hairy Cell Leukemia Therapeutics Product One of Novartis AG Table Representative Hairy Cell Leukemia Therapeutics Product Two of Novartis AG Table Hairy Cell Leukemia Therapeutics Sales, Revenue, Price and Gross Margin of Novartis AG 2013-2017